Development Townhall

Discussion in 'Novartis' started by Anonymous, Apr 15, 2014 at 2:55 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Good job for running it behind closed doors from an empty auditorium in Basel in video-conference with a Funeral Home in EH.
    Summary statistics:
    Flexibility: mentioned 267 times
    Global footprint: 167 times

    It also looks like the cuts in development have been made to satisfy OUR (employees) request for a more agile and less bureaucratic organization as per GES.

    We must have a very creative people in Communications. we should use their talent more.
    Likewise, we have some British scientist-aristocrat taking care of the interior design of our HQ.
    It's exciting to be here, still...
     

  2. Anonymous

    Anonymous Guest

    well there you have it
    just tell them you prefer LESS flexibility
    & they will hire them all back
    Since they seem to abide by what
    the employees "FEEL"
     
  3. Anonymous

    Anonymous Guest

    Brilliant spin doctors. they shit in your shoes and then pull the laces. And guess what: you all deserved it.
     
  4. Anonymous

    Anonymous Guest

    The script they were all reading from was so tight it could have been a teleprompter. i.e. AGILE was code for "easily disposed of headcount to preserve P/L".

    This is all being done for the higher mission of "delivering the pipeline for the patients [and maintain profits of 9 billion/year] [and ensure that salary ratio of CEO:average worker remains 300:1]". SERIOUSLY? You ALL could say it with a straight face and without the subtext?

    The cover story and script for this layoff is particularly sanctimonious sounding - like they really had to add "for the greater future good" coating over an especially offending economic dog turd root cause. Had those wiser, more knowing, wizards of industry not laid off, closed plants and reduced the sales force, the absolutely critically important mission of renovating their summer homes in the south of France or the Hamptons might be delayed. This in turn may have prevented their nannies, wives and mistresses from getting sufficient relief and their children to become cranky. The cascade would be DEVASTATING to the delicate balance of global drug development, approval and distribution.
     
  5. Anonymous

    Anonymous Guest

    Patrice was the only grown up at the table. Tim is one of those brilliantly stupid professors that no one is willing to tell him his fly is down, Dave was reading from a TelePrompter and had no thoughts of his own, John looked like he was going to throw up the whole time, and Shreeram looked like he hadn't slept in months. Please, do us all a favor and just say that your talent pool is too expensive to be able to provide nice enough returns for your stakeholders. That you'd rather take the bonuses, stocks, and salaries and put it into untalented but cheap labor in India and Dublin. I particularly am amused by our "new" position that we (NVS) have been in India for "over 6 decades". Oh, OK, we have been doing world class drug development in India for 60 years. What kind of idiots do you take us for?
     
  6. Anonymous

    Anonymous Guest

    More serelaxins please.... And may there be more failures for a company that cares so much for the bottom line.
     
  7. Anonymous

    Anonymous Guest

    The "world class" Develolment in the US has been producing mostly me to drugs for the past 30 plus years. So they don't have much too loose by switching their bets from you to anywhere else.
     
  8. Anonymous

    Anonymous Guest

    Dec 2011 - Science, published by the AAAS.

    "According to the Factbook, the pharmaceutical industry discovered and released on the global market just 21 "new molecular entities" in 2010. (A significant number of new drugs each year are derived from already marketed drugs."

    Hemorrhaging jobs

    Expert observers believe that big pharma is stuck, largely due to a broken drug discovery process. “Everyone’s frantically trying to come up with something because of course the rewards of finding a good drug that meets an unmet medical need … are tremendous still,” Lowe says. But, right now, “no one really knows how to increase the number of clinical successes.” All we really know how to do is to "cut costs on the other end,” he says.

    "Whether big pharma will ever come back is another open question".

    http://sciencecareers.sciencemag.org...redit.a1100136
     
  9. Anonymous

    Anonymous Guest

    Thats easy, because Patrice doesn't give a fuck about anybody in the Company except himself, his wife and may be his spineless yes-men reporting to him.
     
  10. Anonymous

    Anonymous Guest

    It's really out of their hands anyway isn't it? Are we really critiquing how the Captain of the Titanic would explain to the passengers how the ship was sinking while it was happening?
     
  11. Anonymous

    Anonymous Guest

    Don't forget the yes-women...

    Oh and he's likely gone soon...